RGEN reports Tuesday, Feb 23, 2027, before the open. After the last 4 reports the stock moved −2.4%, +10.9%, +6.3%, −0.5% the next day.
EPS 0.53 against an estimate of 0.46 (+14.5% surprise). The stock moved −2.4% the next trading day.
RGEN is expected to report on Tuesday, Feb 23, 2027, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Oct 27, 2026 | 0.46 | 0.53 | −2.4% | −4.0% |
| Jul 28, 2026 | 0.45 | 0.54 | +10.9% | +12.2% |
| May 5, 2026 | 0.39 | 0.48 | +6.3% | −1.9% |
| Feb 24, 2026 | 0.44 | 0.49 | −0.5% | −7.7% |
| Oct 28, 2025 | 0.42 | 0.46 | −5.9% | −6.8% |
| Jul 29, 2025 | 0.39 | 0.37 | +4.7% | −2.6% |
| Apr 29, 2025 | 0.35 | 0.39 | −2.9% | −1.9% |
| Feb 20, 2025 | 0.41 | 0.44 | +7.9% | +8.0% |
Average move the next trading day over the last 8 reports: ±5.2% (4 of 8 up).
RGEN is in an uptrend, momentum soft. $194.57 is the level overhead; $177.82 the first support below.
RGEN at $178.27. Nearest resistance $194.57 (+9.1%). Nearest support $177.82 (−0.3%).
RGEN chart, levels and analysis · Earnings this week
RGEN is expected to report on Tuesday, Feb 23, 2027, before the open.
RGEN reports before the open, US Eastern time.
After its report on Oct 27, 2026, RGEN moved −2.4% the next trading day.
Over the last 8 reports, RGEN moved 5.2% on average the next trading day, up 4 times out of 8.